欧文原著論文
1999-2000年
2000 1 Tomiyama, H., Yamada, N., Komatsu, H., Hirayama, K. and Takiguchi, M. (2000) A single CTL clone can recogniza a naturally processed HIV-1 epitope presented by two diffrent HLA class I molecules. Eur. J. Immunol. 30:2521-2530. [要旨]
2 Tomiyama, H., Oka, S., Ogg, GS., Ida, S., McMichael, AJ., Takiguchi, M. (2000) Expansion of HIV-1-specific CD28- CD45RA- CD8+ T cells in chronically HIV-1-infected individuals. AIDS. 14(13):2049-2051. [要旨]
3 Eura, M., Chikamatsu, K., Katsura, F., Obata, A., Sobao, Y., Takiguchi, M., Song, Y., Appella, E., Whiteside, TL., DeLeo, AB. (2000) A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck. Clin Cancer Res. 6(3):979-986.
4 Takiguchi, M., Matsuda, T., Tomiyama, H. and Miwa, K. (2000) Analysis of three HLA-A*3303 binding peptide anchors using an HLA-A*3303 stabilization assay. Tissue Antigens. 55:296-302. [Abstract]
5

Maenaka, K., Maenaka, T., Tomiyama, H., Takiguchi, M., David, I Stuart., E. Yvonne Jones. (2000) Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes. J. Immunol. 165:3268-3274.

6 Fujiki, Y., Onodera, M., Yamaguchi, T., Osawa, M., Sudo, K., Hamada, H., Ema, D., Shibuya, A., Takiguchi, M., Kubo, T. and Nakauchi, H. (2000) Dominant expansion of human T cells in non-obese diabetic/severe combines immunodeficiency mice implanted with human bone fragments. Experimental Hematology. 28: 792-801.
7

Takiguchi, M., Matsuda, T., Tomiyama, H. (2000) Polarity of the P1 anchor residue determines peptide binding specificity between HLA-A*3101 and HLA-A*3303. Tissue Antigens. 56: 501-506.

1999 8 Fukada, K., Tomiyama. H., Chujoh, Y., Miwa, K., Kaneko, Y., Oka, S., and Takiguchi, M. (1999) HLA-A*1101-restricted CTL recognition for a novel epitope derived from the HIV-1 Env protein. AIDS. 13: 2597-2599. 
9 Yamada, N., Ishikawa, Y., Dumrese, T., Tokunaga, K., Juji, T., Nagatani, T., Miwa, K., Rammensee, HGG., Takiguchi, M. (1999) Role of anchor residues in peptide binding to three HLA-A26 molecules. Tissue Antigens. 54(4):325-332. [Abstract]
10

Ando, Y., Beck, Y., Tomikawa, S., Eriguchi, M., Muto, T. and Takiguchi, M. (1999) Cell-mediated graft rejection observed in two lines of Human histocompatibility leukocyte antigen class I transgenic mice. Transplantation. 68(6):904-908.

11 Fukada, K., Tomiyama, H., Chijoh, Y., Miwa, K., Kaneko, Y., Oka, S., Takiguchi, M. (1999) HLA-A*1101-restricted cytotoxic T lymphocyte recognition for a novel epitope derived from the HIV-1 Env protein. AIDS. 13(18):2597-2599.
12

Kawana, A., Tomiyama, H., Takiguchi, M., Shioda, T., Nakamura, T., Iwamoto, A. (1999) Accumulation of specific amino acid substitutions in HLA-B35-restricted human immunodeficiency virus type 1 cytotoxic T lymphocyte epitopes. AIDS. Res. Hum. Retroviruses. 15(12):1099-1107.

13 Sobao, Y., Miwa, K., Takiguchi, M. (1999) The role of the amino acids associated with the HLA-Bw4/Bw6 epitope in peptide binding to HLA-B5, B35 CREG molecules. Immunogenetics. 49(9):819-822.
14 Oiso, M., Eura, M., Katsura, F., Takiguchi, M., Sobao, Y., Masuyama, K., Nakashima, M., Itoh, K., Ishikawa, T. (1999) A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes. Int. J. Cancer. 81(3):387-394.
15

Tomiyama, H., Chujoh, Y., Shioda, T., Miwa, K., Oka, S., Kaneko, Y., Takiguchi, M. (1999) Cytotoxic T lymphocyte recognition of HLA-B*5101-restricted HIV-1 Rev epitope which is naturally processed in HIV-1-infected cells. AIDS. 13(7):861-863.

16 Tomiyama, H., Sakaguchi, T., Miwa, K., Oka, S., Iwamoto, A., Kaneko, Y., Takiguchi, M. (1999) Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules. Hum. Immunol. 1999. 60(3):177-186. 
17

Sobao, Y., Ysuchiya, N., Takiguchi, M., Tokunaga, K. (1999) Overlapping peptide-binding specificities of HLA-B27 and B39: evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies. Arthritis Rheum. 42(1):175-181.


業績一覧へ戻る